High-throughput screen reveals purinergic receptor as a therapeutic target in circadian β-cell failure
Ontology highlight
ABSTRACT: We report a screen of 2,640 pharmacologically-active compounds in clock-deficient pancreatic β cells and reveal a mechanism by which ivermectin induces insulin secretion and regulates transcription in wild type and P2ry1 receptor knockout BetaTC6 β-cell lines by mRNA-seq.
ORGANISM(S): Mus musculus
PROVIDER: GSE186469 | GEO | 2021/11/03
REPOSITORIES: GEO
ACCESS DATA